BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2018
View Archived Issues
VEGF-D found as a potential new biomarker of heart failure
Read More
HE-4 is a novel prognostic marker for dilated cardiomyopathy
Read More
Sanofi Genzyme declines opt-in on development and commercialization of lumasiran
Read More
Sarepta plans rolling NDA submission to seek accelerated approval of golodirsen for DMD
Read More
SNA-125 begins proof-of-concept trial in atopic dermatitis
Read More
MIDD-0301 described as a novel GABA(A) receptor ligand with clinical potential for asthma
Read More
Ritter announces microbiome data from phase IIb study of RP-G28
Read More
CAD-1883 begins phase I trial for SCA and essential tremor
Read More
EMA validates MAA for Xyndari for sickle cell disease
Read More
Phase II data presented for JVS-100 in patients with critical limb ischemia
Read More
Phase III RESULT study of Sollpura does not meet primary endpoint
Read More
Athersys and Healios plan expansion of MultiStem collaboration
Read More
FDA grants breakthrough therapy designation for CFTR amplifier PTI-428
Read More
Altimmune reports preclinical data comparing SparVax-L and BioThrax against anthrax infection
Read More
Biogen to acquire PF-04958242 from Pfizer
Read More
YIR-821 shows promise for HIV infection
Read More
FDA places clinical hold on phase I/II study of axalimogene filolisbac with durvalumab
Read More
UCL studies FLT180a gene therapy in patients with hemophilia B
Read More
Purdue Research Foundation patents FLT3 inhibitors
Read More
Curadim initiates phase I trials of CP-1050 in U.K.
Read More
Neuro-Bio divulges novel nicotinic receptor modulators
Read More
Aldeyra Therapeutics identifies aldehyde-trapping compounds
Read More
Merck & Co. discovers FXIa and plasma kallikrein inhibitors
Read More
